{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:39:56Z","timestamp":1790480396223,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00117-020-00781-4","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:03:13Z","timestamp":1609718593000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["MR-guided radiotherapy of moving targets","MR-gest\u00fctzte Strahlentherapie beweglicher Zielobjekte"],"prefix":"10.1007","volume":"61","author":[{"given":"C. Katharina","family":"Spindeldreier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kl\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Hoegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Buchele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Rippke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Tonndorf-Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"H\u00f6rner-Rieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"issue":"1","key":"781_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1748-717X-9-12","volume":"9","author":"T Bostel","year":"2014","unstructured":"Bostel\u00a0T et al (2014) MR-guidance\u2014a\u00a0clinical study to evaluate a\u00a0shuttle-based MR-linac connection to provide MR-guided radiotherapy. Radiat Oncol 9(1):12","journal-title":"Radiat Oncol"},{"issue":"3","key":"781_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.semradonc.2014.02.012","volume":"24","author":"DA Jaffray","year":"2014","unstructured":"Jaffray\u00a0DA et\u00a0al (2014) A facility for magnetic resonance\u2013guided radiation therapy. Semin Radiat Oncol 24(3):193\u2013195","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"781_CR3","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.ijrobp.2009.01.065","volume":"74","author":"M Karlsson","year":"2009","unstructured":"Karlsson\u00a0M et\u00a0al (2009) Dedicated magnetic resonance imaging in the radiotherapy clinic. Int J Radiat Oncol Biol Phys 74(2):644\u2013651","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"781_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.clon.2018.08.010","volume":"30","author":"LE Henke","year":"2018","unstructured":"Henke\u00a0LE et al (2018) Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-year clinical experience. Clin Oncol 30(11):720\u2013727","journal-title":"Clin. Oncol."},{"issue":"3","key":"781_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.adro.2017.05.006","volume":"2","author":"BW Fischer-Valuck","year":"2017","unstructured":"Fischer-Valuck\u00a0BW et al (2017) Two-and-a-half-year clinical experience with the world\u2019s first magnetic resonance image guided radiation therapy system. Adv Radiat Oncol 2(3):485\u2013493","journal-title":"Adv Radiat Oncol"},{"key":"781_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ctro.2019.04.007","volume":"18","author":"S Kl\u00fcter","year":"2019","unstructured":"Kl\u00fcter\u00a0S (2019) Technical design and concept of a\u00a00.35\u202fT MR-Linac. Clin Translat Radiat Oncol 18:98\u2013101","journal-title":"Clin Translat Radiat Oncol"},{"issue":"23","key":"781_CR7","doi-asserted-by":"publisher","first-page":"L41","DOI":"10.1088\/1361-6560\/aa9517","volume":"62","author":"BW Raaymakers","year":"2017","unstructured":"Raaymakers\u00a0BW et al (2017) First patients treated with a\u00a01.5\u202fT MRI-Linac: clinical proof of concept of a\u00a0high-precision, high-field MRI guided radiotherapy treatment. Phys Med Biol 62(23):L41\u2013L50","journal-title":"Phys Med Biol"},{"issue":"12","key":"781_CR8","doi-asserted-by":"publisher","first-page":"N229","DOI":"10.1088\/0031-9155\/54\/12\/N01","volume":"54","author":"BW Raaymakers","year":"2009","unstructured":"Raaymakers\u00a0BW et\u00a0al (2009) Integrating a\u00a01.5\u202fT MRI scanner with a\u00a06\u00a0MV accelerator: proof of concept. Phys Med Biol 54(12):N229\u2013N237","journal-title":"Phys Med Biol"},{"key":"781_CR9","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1002\/mp.13002","volume":"45","author":"OL Green","year":"2018","unstructured":"Green\u00a0OL et al (2018) First clinical implementation of real-time, real anatomy tracking and radiation beam control. Med Phys 45:3728\u20133740","journal-title":"Med Phys"},{"issue":"8","key":"781_CR10","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s00117-018-0420-6","volume":"58","author":"NG Burnet","year":"2018","unstructured":"Burnet\u00a0NG et\u00a0al (2018) Zielvolumenkonzepte in der Strahlentherapie und ihre Bedeutung f\u00fcr die Bildgebung. Radiologe 58(8):708\u2013721","journal-title":"Radiologe"},{"key":"781_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.radonc.2018.11.019","volume":"132","author":"O Bohoudi","year":"2019","unstructured":"Bohoudi\u00a0O et al (2019) Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy. Radiother Oncol 132:16\u201322","journal-title":"Radiother Oncol"},{"issue":"4","key":"781_CR12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ijrobp.2016.08.006","volume":"96","author":"S Acharya","year":"2016","unstructured":"Acharya\u00a0S et al (2016) Magnetic resonance image guided radiation therapy for external beam accelerated partial-breast irradiation: evaluation of delivered dose and Intrafractional cavity motion. Int J Radiat Oncol Biol Phys 96(4):785\u2013792","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"781_CR13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ijrobp.2018.06.002","volume":"102","author":"MA Palacios","year":"2018","unstructured":"Palacios\u00a0MA et al (2018) Role of daily plan adaptation in MR-guided stereotactic ablative radiation therapy for adrenal metastases. Int J Radiat Oncol Biol Phys 102(2):426\u2013433","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"781_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.adro.2018.08.005","volume":"4","author":"SA Rosenberg","year":"2019","unstructured":"Rosenberg\u00a0SA et al (2019) A multi-institutional experience of MR-guided liver stereotactic body radiation therapy. Adv Radiat Oncol 4(1):142\u2013149","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"781_CR15","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.ijrobp.2019.08.007","volume":"105","author":"AME Bruynzeel","year":"2019","unstructured":"Bruynzeel\u00a0AME et al (2019) A prospective single-arm phase 2 study of stereotactic magnetic resonance guided adaptive radiation therapy for prostate cancer: early toxicity results. Int J Radiat Oncol Biol Phys 105(5):1086\u20131094","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"781_CR16","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1002\/cam4.2100","volume":"8","author":"S Rudra","year":"2019","unstructured":"Rudra\u00a0S et al (2019) Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer Med 8(5):2123\u20132132","journal-title":"Cancer Med"},{"issue":"3","key":"781_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.radonc.2009.08.040","volume":"93","author":"H Hof","year":"2009","unstructured":"Hof\u00a0H et al (2009) 4D-CT-based target volume definition in stereotactic radiotherapy of lung tumours: comparison with a\u00a0conventional technique using individual margins. Radiother Oncol 93(3):419\u2013423","journal-title":"Radiother Oncol"},{"key":"781_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00066-020-01578-z","volume":"196","author":"S Kl\u00fcter","year":"2020","unstructured":"Kl\u00fcter\u00a0S et al (2020) First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany. Strahlenther Onkol 196:691\u2013698","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"781_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.radonc.2018.07.025","volume":"129","author":"D Cusumano","year":"2018","unstructured":"Cusumano\u00a0D et\u00a0al (2018) Predicting tumour motion during the whole radiotherapy treatment: a\u00a0systematic approach for thoracic and abdominal lesions based on real time MR. Radiother Oncol 129(3):456\u2013462","journal-title":"Radiother Oncol"},{"issue":"4","key":"781_CR20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0360-3016(02)02803-1","volume":"53","author":"Y Seppenwoolde","year":"2002","unstructured":"Seppenwoolde\u00a0Y et al (2002) Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys 53(4):822\u2013834","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"781_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.radonc.2017.09.001","volume":"126","author":"J Dhont","year":"2018","unstructured":"Dhont\u00a0J et al (2018) The long- and short-term variability of breathing induced tumor motion in lung and liver over the course of a\u00a0radiotherapy treatment. Radiother Oncol 126(2):339\u2013346","journal-title":"Radiother Oncol"},{"issue":"1","key":"781_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","volume":"30","author":"GG Hanna","year":"2018","unstructured":"Hanna\u00a0GG et\u00a0al (2018) UK consensus on normal tissue dose constraints for stereotactic radiotherapy. Clin Oncol (R Coll Radiol) 30(1):5\u201314","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"10","key":"781_CR23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00066-014-0714-1","volume":"190","author":"F Sterzing","year":"2014","unstructured":"Sterzing\u00a0F et\u00a0al (2014) Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 190(10):872\u2013881","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"781_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00066-013-0450-y","volume":"190","author":"M Guckenberger","year":"2014","unstructured":"Guckenberger\u00a0M et al (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190(1):26\u201333","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"781_CR25","first-page":"e2422","volume":"10","author":"K Mittauer","year":"2018","unstructured":"Mittauer\u00a0K et al (2018) A new era of image guidance with magnetic resonance-guided radiation therapy for abdominal and thoracic malignancies. Cureus 10(4):e2422","journal-title":"Cureus"},{"issue":"1","key":"781_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13014-019-1308-y","volume":"14","author":"S Corradini","year":"2019","unstructured":"Corradini\u00a0S et al (2019) MR-guidance in clinical reality: current treatment challenges and future perspectives. Radiat Oncol 14(1):92","journal-title":"Radiat Oncol"},{"issue":"9","key":"781_CR27","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1002\/mp.13657","volume":"46","author":"JE Bayouth","year":"2019","unstructured":"Bayouth\u00a0JE, Low\u00a0DA, Zaidi\u00a0H (2019) MRI-linac systems will replace conventional IGRT systems within 15\u00a0years. Med Phys 46(9):3753\u20133756","journal-title":"Med Phys"},{"issue":"11","key":"781_CR28","doi-asserted-by":"publisher","first-page":"111704","DOI":"10.1118\/1.4896821","volume":"41","author":"Y Akino","year":"2014","unstructured":"Akino\u00a0Y et al (2014) Evaluation of potential internal target volume of liver tumors using cine-MRI. Med Phys 41(11):111704","journal-title":"Med Phys"},{"issue":"1","key":"781_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13014-020-01530-6","volume":"15","author":"D Cusumano","year":"2020","unstructured":"Cusumano\u00a0D et\u00a0al (2020) Reliability of ITV approach to varying treatment fraction time: a\u00a0retrospective analysis based on 2D cine MR images. Radiat Oncol 15(1):152","journal-title":"Radiat Oncol"},{"issue":"2","key":"781_CR30","first-page":"e2236","volume":"10","author":"S Tetar","year":"2018","unstructured":"Tetar\u00a0S et al (2018) Patient-reported outcome measurements on the tolerance of magnetic resonance imaging-guided radiation therapy. Cureus 10(2):e2236","journal-title":"Cureus"},{"issue":"12","key":"781_CR31","first-page":"e6457","volume":"11","author":"B Sahin","year":"2019","unstructured":"Sahin\u00a0B et al (2019) First 500 fractions delivered with a\u00a0magnetic resonance-guided radiotherapy system: initial experience. Cureus 11(12):e6457","journal-title":"Cureus"},{"issue":"2","key":"781_CR32","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.radonc.2015.10.024","volume":"118","author":"AP Wojcieszynski","year":"2016","unstructured":"Wojcieszynski\u00a0AP et al (2016) Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liver. Radiother Oncol 118(2):416\u2013418","journal-title":"Radiother Oncol"},{"issue":"3","key":"781_CR33","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1118\/1.4942381","volume":"43","author":"Y Yang","year":"2016","unstructured":"Yang\u00a0Y et al (2016) Longitudinal diffusion MRI for treatment response assessment: preliminary experience using an MRI-guided tri-cobalt 60 radiotherapy system. Med Phys 43(3):1369\u20131373","journal-title":"Med Phys"},{"issue":"1098","key":"781_CR34","doi-asserted-by":"publisher","first-page":"20180670","DOI":"10.1259\/bjr.20180670","volume":"92","author":"IM White","year":"2019","unstructured":"White\u00a0IM et\u00a0al (2019) Realizing the potential of magnetic resonance image guided radiotherapy in gynaecological and rectal cancer. Br J Radiol 92(1098):20180670","journal-title":"Br J Radiol"},{"issue":"1071","key":"781_CR35","doi-asserted-by":"publisher","first-page":"20160739","DOI":"10.1259\/bjr.20160739","volume":"90","author":"N Shaverdian","year":"2017","unstructured":"Shaverdian\u00a0N et al (2017) Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer. Br J Radiol 90(1071):20160739","journal-title":"Br J Radiol"},{"key":"781_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejca.2019.07.021","volume":"122","author":"WA Hall","year":"2019","unstructured":"Hall\u00a0WA et al (2019) The transformation of radiation oncology using real-time magnetic resonance guidance: a review. Eur J Cancer 122:42\u201352","journal-title":"Eur J Cancer"},{"issue":"11","key":"781_CR37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.clon.2018.08.001","volume":"30","author":"A Hunt","year":"2018","unstructured":"Hunt\u00a0A et\u00a0al (2018) Adaptive radiotherapy enabled by MRI guidance. Clin Oncol 30(11):711\u2013719","journal-title":"Clin Oncol"},{"key":"781_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.radonc.2019.01.024","volume":"134","author":"AM Werensteijn-Honingh","year":"2019","unstructured":"Werensteijn-Honingh\u00a0AM et al (2019) Feasibility of stereotactic radiotherapy using a\u00a01.5T MR-linac: multi-fraction treatment of pelvic lymph node oligometastases. Radiother Oncol 134:50\u201354","journal-title":"Radiother Oncol"},{"issue":"1","key":"781_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.adro.2018.10.003","volume":"4","author":"LE Henke","year":"2019","unstructured":"Henke\u00a0LE et al (2019) Stereotactic MR-guided online Adaptive Radiation Therapy (SMART) for ultracentral thorax malignancies: results of a\u00a0phase 1 trial. Adv Radiat Oncol 4(1):201\u2013209","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"781_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13014-020-01641-0","volume":"15","author":"JE van Timmeren","year":"2020","unstructured":"van Timmeren\u00a0JE et al (2020) Treatment plan quality during online adaptive re-planning. Radiat Oncol 15(1):203","journal-title":"Radiat Oncol"}],"container-title":["Der Radiologe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-020-00781-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-020-00781-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-020-00781-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T13:02:58Z","timestamp":1641906178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-020-00781-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":40,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s00117-020-00781-4","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"18 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"J.\u00a0H\u00f6rner-Rieber and S.\u00a0Kl\u00fcter received speaker fees and travel reimbursement from ViewRay Inc. J.\u00a0H\u00f6rner-Rieber received travel reimbursement from IntraOP Medical and Elekta Instrument AB. She also received a grant from IntraOP Medical. J.\u00a0Debus received grants from CRI (The Clinical Research Institute GmbH), View Ray Inc., Accuray International, Accuray Incorporated, RaySearch Laboratories AB, Vision RT limited, Astellas Pharma GmbH, Merck Serono GmbH, AstraZeneca GmbH, Solution Akademie GmbH, Ergomed PLC Surrey Research Park, Siemens Healthcare GmbH, Quintiles GmbH, Pharmaceutical Research Associates GmbH, Boehringer Ingelheim Pharma GmbH Co, PTW-Freiburg Dr. Pychlau GmbH, Nanobiotix A.A., as well as IntraOP Medical. He has a research agreement with ViewRay Inc. and is a member of the Scientific Advisory Board of ViewRay Inc. (Oakwood, OH, USA). C.K.\u00a0Spindeldreier, P.\u00a0Hoegen, C.\u00a0Buchele, C.\u00a0Rippke, and E.\u00a0Tonndorf-Martini declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}